Phase II study of sitravatinib in combination with tislelizumab in patients with advanced biliary tract cancer who have failed to at least 1 prior systemic treatment: Trial in progress

被引：0
|
作者：
Oh, Do-Youn
Kim, Jin Won
Chon, Hongjae
Lee, Choong-Kun
Kim, Ji-Won
Kang, Beodeul
Choi, Hye Jin
Park, Se Jun
Yoon, Jeesun
Lee, Myung Ah
机构：
[1] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Canc Res Inst,Coll Med, Seoul, South Korea
[2] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea
[3] CHA Univ, CHA Bundang Med Ctr, Med Oncol, Seongnam, South Korea
[4] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med,Div Med Oncol, Seoul, South Korea
[5] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Seongnam, South Korea
[6] Yonsei Univ, Dept Internal Med, Yonsei Canc Ctr, Coll Med,Div Med Oncol, Seoul, South Korea
[7] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Coll Med,Div Oncol, Seoul, South Korea
[8] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Coll Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.TPS490
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS490
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Multicenter phase II study of docetaxel and oxaliplatin combination in patients with locally advanced or metastatic biliary tract cancer.
    Song, Eun-Kee
    Han, Hye-Suk
    Lee, Ki Hyeong
    Lee, Kyu Taek
    Bae, Sang Byung
    Kim, Han Jo
    Kim, Samyong
    Yun, Hwan Jung
    Cho, Sang Hoe
    Shim, Hyun-Jeong
    Yhim, Ho-Young
    Leo, Na-Ri
    Joon, So Yoon
    Yim, Chang-Yeoi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] Trial in progress: A phase 2/3 randomized, controlled study of CTX-009 in combination with paclitaxel versus paclitaxel alone in adult patients with unresectable advanced, metastatic or recurrent biliary tract cancers who have received one prior systemic chemotherapy regimen.
    Fontaine, Marilyn
    Pilgrim, Sarah
    Schuetz, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS640 - TPS640
  • [33] Phase II study of topotecan and bevacizumab in patients with metastatic non-small cell lung cancer who have failed prior systemic chemotherapy - interim analysis
    Beitinjaneh, A.
    Dudek, A. Z.
    EJC SUPPLEMENTS, 2009, 7 (02): : 545 - 545
  • [34] Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer
    Kim, Hyeong Su
    Kim, Ho Young
    Zang, Dae Young
    Oh, Ho Suk
    Jeon, Jang Yong
    Cho, Ji Woong
    Park, Choong Kee
    Kim, Jong Hyeok
    Kim, Min-Jeong
    Ha, Hong Il
    Kim, Jung Han
    Han, Boram
    Song, Hunho
    Kwon, Jung Hye
    Choi, Dae Ro
    Jung, Joo Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (04) : 711 - 718
  • [35] Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer
    Hyeong Su Kim
    Ho Young Kim
    Dae Young Zang
    Ho Suk Oh
    Jang Yong Jeon
    Ji Woong Cho
    Choong Kee Park
    Jong Hyeok Kim
    Min-Jeong Kim
    Hong Il Ha
    Jung Han Kim
    Boram Han
    Hunho Song
    Jung Hye Kwon
    Dae Ro Choi
    Joo Young Jung
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 711 - 718
  • [36] S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study
    Junji Furuse
    Takuji Okusaka
    Narikazu Boku
    Shinichi Ohkawa
    Akira Sawaki
    Toshikazu Masumoto
    Akihiro Funakoshi
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 849 - 855
  • [37] S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study
    Furuse, Junji
    Okusaka, Takuji
    Boku, Narikazu
    Ohkawa, Shinichi
    Sawaki, Akira
    Masumoto, Toshikazu
    Funakoshi, Akihiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 849 - 855
  • [38] Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer
    Takuji Okusaka
    Hiroshi Ishii
    Akihiro Funakoshi
    Kenji Yamao
    Shinichi Ohkawa
    Soh Saito
    Hiroshi Saito
    Toshio Tsuyuguchi
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 647 - 653
  • [39] Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer
    Okusaka, T
    Ishii, H
    Funakoshi, A
    Yamao, K
    Ohkawa, S
    Saito, S
    Saito, H
    Tsuyuguchi, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (05) : 647 - 653
  • [40] Phase II trial of S-1 in combination with oxaliplatin in previously untreated patients with recurrent or inoperable biliary tract cancer
    Oh, Sung Yong
    Lee, Gyeong-Won
    Kim, Hoon Gu
    Kim, Tae Hyo
    Kim, Hyun Jin
    Kang, Jung Hun
    CHEMOTHERAPY, 2008, 54 (06) : 479 - 484
12345